FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200531805> ?p ?o ?g. }

• W4200531805 endingPage "419" @default.
• W4200531805 startingPage "401" @default.
• W4200531805 abstract "Rituximab is the standard therapy for childhood-onset complicated frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, most patients redevelop FRNS/SDNS after peripheral B cell recovery.We conducted a multicenter, randomized, double-blind, placebo-controlled trial to examine whether mycophenolate mofetil (MMF) administration after rituximab can prevent treatment failure (FRNS, SDNS, steroid resistance, or use of immunosuppressive agents or rituximab). In total, 39 patients (per group) were treated with rituximab, followed by either MMF or placebo until day 505 (treatment period). The primary outcome was time to treatment failure (TTF) throughout the treatment and follow-up periods (until day 505 for the last enrolled patient).TTFs were clinically but not statistically significantly longer among patients given MMF after rituximab than among patients receiving rituximab monotherapy (median, 784.0 versus 472.5 days, hazard ratio [HR], 0.59; 95% confidence interval [95% CI], 0.34 to 1.05, log-rank test: P=0.07). Because most patients in the MMF group presented with treatment failure after MMF discontinuation, we performed a post-hoc analysis limited to the treatment period and found that MMF after rituximab prolonged the TTF and decreased the risk of treatment failure by 80% (HR, 0.20; 95% CI, 0.08 to 0.50). Moreover, MMF after rituximab reduced the relapse rate and daily steroid dose during the treatment period by 74% and 57%, respectively. The frequency and severity of adverse events were similar in both groups.Administration of MMF after rituximab may sufficiently prevent the development of treatment failure and is well tolerated, although the relapse-preventing effect disappears after MMF discontinuation." @default.
• W4200531805 created "2021-12-31" @default.
• W4200531805 creator A5000523070 @default.
• W4200531805 creator A5003504692 @default.
• W4200531805 creator A5005869115 @default.
• W4200531805 creator A5007720060 @default.
• W4200531805 creator A5011346273 @default.
• W4200531805 creator A5014914035 @default.
• W4200531805 creator A5019540296 @default.
• W4200531805 creator A5019849445 @default.
• W4200531805 creator A5022766840 @default.
• W4200531805 creator A5022908257 @default.
• W4200531805 creator A5024918216 @default.
• W4200531805 creator A5027021559 @default.
• W4200531805 creator A5030921201 @default.
• W4200531805 creator A5033754308 @default.
• W4200531805 creator A5033787199 @default.
• W4200531805 creator A5036822255 @default.
• W4200531805 creator A5037618983 @default.
• W4200531805 creator A5040130245 @default.
• W4200531805 creator A5049494554 @default.
• W4200531805 creator A5051867714 @default.
• W4200531805 creator A5052128000 @default.
• W4200531805 creator A5052812818 @default.
• W4200531805 creator A5053311711 @default.
• W4200531805 creator A5055654047 @default.
• W4200531805 creator A5061913940 @default.
• W4200531805 creator A5065837353 @default.
• W4200531805 creator A5072056487 @default.
• W4200531805 creator A5081256427 @default.
• W4200531805 creator A5083303913 @default.
• W4200531805 creator A5084675851 @default.
• W4200531805 creator A5085246335 @default.
• W4200531805 creator A5087992950 @default.
• W4200531805 creator A5088448746 @default.
• W4200531805 creator A5090555589 @default.
• W4200531805 date "2022-02-01" @default.
• W4200531805 modified "2023-10-14" @default.
• W4200531805 title "Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome" @default.
• W4200531805 cites W1980836240 @default.
• W4200531805 cites W1983663249 @default.
• W4200531805 cites W1983883436 @default.
• W4200531805 cites W1988812807 @default.
• W4200531805 cites W2003607385 @default.
• W4200531805 cites W2005367998 @default.
• W4200531805 cites W2012053212 @default.
• W4200531805 cites W2018799387 @default.
• W4200531805 cites W2040841525 @default.
• W4200531805 cites W2050498243 @default.
• W4200531805 cites W2054404003 @default.
• W4200531805 cites W2074749875 @default.
• W4200531805 cites W2086455046 @default.
• W4200531805 cites W2087953943 @default.
• W4200531805 cites W2108455316 @default.
• W4200531805 cites W2115135526 @default.
• W4200531805 cites W2117257280 @default.
• W4200531805 cites W2127544448 @default.
• W4200531805 cites W2156785239 @default.
• W4200531805 cites W2161254226 @default.
• W4200531805 cites W2214737321 @default.
• W4200531805 cites W2513795131 @default.
• W4200531805 cites W2609602266 @default.
• W4200531805 cites W2735768344 @default.
• W4200531805 cites W2808503484 @default.
• W4200531805 cites W2944257434 @default.
• W4200531805 cites W2966784815 @default.
• W4200531805 cites W2976155788 @default.
• W4200531805 cites W2981689828 @default.
• W4200531805 cites W2986856572 @default.
• W4200531805 cites W3013380967 @default.
• W4200531805 cites W3037451524 @default.
• W4200531805 cites W3156996711 @default.
• W4200531805 cites W4210848327 @default.
• W4200531805 cites W4211034600 @default.
• W4200531805 cites W4212860823 @default.
• W4200531805 cites W4288101131 @default.
• W4200531805 doi "https://doi.org/10.1681/asn.2021050643" @default.
• W4200531805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34880074" @default.
• W4200531805 hasPublicationYear "2022" @default.
• W4200531805 type Work @default.
• W4200531805 citedByCount "22" @default.
• W4200531805 countsByYear W42005318052022 @default.
• W4200531805 countsByYear W42005318052023 @default.
• W4200531805 crossrefType "journal-article" @default.
• W4200531805 hasAuthorship W4200531805A5000523070 @default.
• W4200531805 hasAuthorship W4200531805A5003504692 @default.
• W4200531805 hasAuthorship W4200531805A5005869115 @default.
• W4200531805 hasAuthorship W4200531805A5007720060 @default.
• W4200531805 hasAuthorship W4200531805A5011346273 @default.
• W4200531805 hasAuthorship W4200531805A5014914035 @default.
• W4200531805 hasAuthorship W4200531805A5019540296 @default.
• W4200531805 hasAuthorship W4200531805A5019849445 @default.
• W4200531805 hasAuthorship W4200531805A5022766840 @default.
• W4200531805 hasAuthorship W4200531805A5022908257 @default.
• W4200531805 hasAuthorship W4200531805A5024918216 @default.
• W4200531805 hasAuthorship W4200531805A5027021559 @default.
• W4200531805 hasAuthorship W4200531805A5030921201 @default.
• W4200531805 hasAuthorship W4200531805A5033754308 @default.

• next